hydroxyurea,Crizanlizumab
Novartis
['hydroxyurea']
spartan-2 ( phase 2 of crizalizumab in rx priapism in scd) n= 24, 58% hydroxyurea, 25% daily, 27% every other day priapism 50%- exhaustion, 40% - strain in relationship 53.1% median reduction in priapic events 72% reduction week 15-26 #ash22
Physician | Chief Fellow @McGovernHemeOnc| IM- @UMassChan @baystateIM l Interests: Thoracic oncology, global onc, #meded, SCD | Tweets are mine